All articles by Clinical Trials Arena Team
Clinical Trials Arena Team
Pipeline Moves: Trial completion bumps advancement prospects for AstraZeneca’s oncology drug
The Clinical Trial Arena team also investigate other assets in oncology, Gaucher disease, bacterial infection, and diabetic eye and kidney disease.
Pipeline Moves: Amgen terminates Phase III osteogenesis imperfecta trial, approval prospects drop
The Clinical Trials Arena Team also reviews assets in oncology, psoriasis and developmental disorder.
Pipeline Moves: AbbVie and Janssen terminate Phase III lymphoma trial, approval prospects plummet
The Clinical Trials Arena team also reviews assets in central nervous system, gastrointestinal, oncology, respiratory diseases.
Pipeline Moves: Novartis completes ulcerative colitis trial, advancement prospects rise
The Clinical Trials Arena team also reviews assets in oncology, paediatric hormone deficiency, diabetic pain and ophthalmology.
Pipeline Moves: Novartis resumes Phase II myelofibrosis trial, oncology trial completions
The Clinical Trials Arena team also investigates the completion of Phase II trials in liver and pulmonary diseases, Phase I/II in paediatric and Phase Ib/IIa colorectal cancer trials.
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Pipeline Moves: approval prospects jump for AstraZeneca’s breast cancer drug
The Clinical Trials Arena team also reviews assets in ophthalmology, multiple sclerosis, and multiple oncology indications.
Pipeline Moves: positive topline results in pulmonary hypertension, genetic and metabolic disorders
The Clinical Trials Arena team also investigates assets in chronic kidney disease, soft tissue sarcoma and haematological malignancies
Pipeline Moves: trial completions in glaucoma, lung, and oncology indications
The Clinical Trials Arena team also reviews a termination in severe swelling and topline results in cervical dystonia trials
Pipeline Moves: trial terminations in colorectal cancer, cardiovascular infections, and kidney injury
The Clinical Trials Arena team also reviews endpoint achievement in liver disease, and trial completions in metabolic syndrome and pouchitis.
Pipeline Moves: Trial completions in Duchenne muscular dystrophy and chronic urticaria
The Clinical Trials Arena team also investigates missed endpoints in wound infections, and terminations in head and neck cancer and liver cancer.